IDH2 and central nervous system cancer: 5-Azacytidine induced tumor regression in a patient-derived IDH1 mutant glioma xenograft model;198 while 5-aza-2′-deoxycytidine effectively suppressed growth in IDH-mutant glioma cells in vitro and in vivo.